Study Reveals Rare Brain Malformations in Children Linked to Protein Misfolding
Researchers have found new insights into how chaperones affect brain development. Frydman, a senior author of the study, noted that all patients examined have one healthy copy of the TRiC gene along with one mutated copy. Two mutated copies would likely lead to severe issues. Despite some patients showing muscular problems, the primary impact is neurological, highlighting the significance of the TRiC chaperone in brain growth.
The researchers studied the TRiC complex in yeast and isolated it in test tubes. Rodriguez-Aliaga, a co-first author, made mutations in yeast that mirrored 22 mutations linked to human diseases. He discovered that while some mutations were lethal to yeast cells, others were not. This variability helps explain the diverse symptoms observed in patients.
Further experiments involved roundworms and zebrafish to explore the effects of the mutations on multicellular organisms. In these species, having one mutated copy of the CCT3 gene, part of the TRiC complex, proved lethal. Some animals with one healthy and one mutated copy survived but presented developmental issues. Zebrafish showed brain development defects similar to those seen in human patients, while worms had movement issues.
The specific misfolded protein causing neurological symptoms remains unclear. Researchers suspect that structural proteins like actin and tubulin, which are important for cell function and stability, play a role and are folded by TRiC. Worms with TRiC mutations exhibited small aggregates of actin, indicating protein misfolding. Mitochondria, which provide energy for neuronal functions, were also affected.
What are chaperone proteins and their role in brain development?
Interview with Dr. Frydman and Dr. Rodriguez-Aliaga: Insights into Chaperone Proteins and Brain Development
NewsDirectory3.com had the opportunity to speak with Dr. Frydman, senior author of the recent pioneering study on chaperones, and Dr. Rodriguez-Aliaga, co-first author, about their groundbreaking findings regarding the role of the TRiC complex in brain development.
NewsDirectory3: Thank you for joining us today, Dr. Frydman and Dr. Rodriguez-Aliaga. Your recent research sheds light on the TRiC chaperone’s role in neurological symptoms related to mutations. Can you provide an overview of your study’s key findings?
Dr. Frydman: Certainly! We discovered that all patients examined carry one healthy copy of the TRiC gene alongside one mutated copy. While two mutated copies could lead to severe neurological issues, the presence of a healthy copy appears to provide a crucial buffer. Our findings emphasize that the primary impact of the TRiC chaperone is on brain growth, even in cases where some patients exhibit muscular problems.
Dr. Rodriguez-Aliaga: In our experiments, we studied the TRiC complex in yeast by creating mutations that mirrored 22 mutations linked to human diseases. What we found was fascinating; although some mutations proved lethal to yeast cells, others did not, which aligns with the variability of symptoms seen in patients with similar mutations.
NewsDirectory3: Fascinating! Your research extended to roundworms and zebrafish. How did these models contribute to your findings?
Dr. Rodriguez-Aliaga: These multicellular organisms provided critical insight. We found that having one mutated copy of the CCT3 gene, which is part of the TRiC complex, resulted in lethality in these models. Interestingly, while some organisms with one healthy and one mutated copy survived, they exhibited developmental issues. For instance, zebrafish demonstrated brain development defects similar to those in human patients, while the roundworms showed movement disorders.
NewsDirectory3: That raises an important question about the underlying mechanism. What did you discover regarding the specific proteins involved in these neurological symptoms?
Dr. Frydman: That’s one of the key points we’re still exploring. We suspect that actin and tubulin, which are essential for maintaining cell structure and function, are misfolded due to TRiC mutations. In fact, we observed small aggregates of actin in worms with TRiC mutations, indicating protein misfolding, and we also noted that mitochondria, which are vital for energy production in neurons, were affected.
NewsDirectory3: It sounds like you’re laying the groundwork for future research. What are your next steps?
Dr. Rodriguez-Aliaga: We plan to further examine how disease-linked mutations impact TRiC’s protein-folding ability. Our upcoming studies will utilize patient-derived cells to grow neurons and brain organoids, allowing us to investigate the specific impacts of these mutations on human brain cells directly.
Dr. Frydman: We believe that this research bridges basic science and medicine, potentially leading to targeted therapies for conditions linked to these mutations. It’s a continuation of over 30 years of biochemistry and biophysics research on TRiC.
NewsDirectory3: Thank you both for sharing your insights. Your research on chaperones and their impact on neurological health is profound and holds great promise for future medical advancements. We look forward to learning more about your findings in the future.
Frydman and Rodriguez-Aliaga plan to study how disease-linked mutations affect TRiC’s ability to fold proteins. They will use patient-derived cells to grow neurons or brain organoids and investigate the mutations’ impact on human brain cells.
Rodriguez-Aliaga stated that this research connects basic science with medicine. The study builds on over 30 years of biochemistry and biophysics research on TRiC.